The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies

Journal of Autoimmunity

Volumn 36, Issue 2, 2011, Pages 98-105

  Irman, Špela ^a   Škarabot, Miha ^b,c   Muševič, Igor ^b,c   Rozman, Blaž ^a   Božič, Borut ^a,c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Annexin A5; Anti annexin antibody; Atomic force microscopy; Crystallization; Planar phospholipid bilayer; Thrombosis

Indexed keywords

ANNEXIN A5 AUTOANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANTIBODY ISOLATION; ANTIGEN ANTIBODY REACTION; AQUEOUS SOLUTION; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; CRYSTALLIZATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; PATHOLOGY; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL;

ANNEXIN A5; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; CRYSTALLIZATION; HUMANS; IMMUNOGLOBULIN G; LIPID BILAYERS; MICROSCOPY, ATOMIC FORCE; MODELS, IMMUNOLOGICAL; MODELS, MOLECULAR;

EID: 79951950352     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.11.003     Document Type: Article

References (40)

1. Matsuda J., Saitoh N., Gohchi K., Gotoh M., Tsukamoto M. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hemathol 1994, 47:56-58.
2. Rodriguez-Garcia M.I., Fernandez J.A., Rodrigez A., Fernandez M.P., Gutierrez C., Torre-Alonso J.C. Annexin V autoantibodies in rheumatoid arthritis. Ann Rheum Dis 1996, 55:895-900.
3. Kaburaki J., Kuwana M., Yamamoto M., Kawai S., Ikeda Y. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol 1997, 54:209-213.
4. Satoh A., Suzuki K., Takayama E., Kojima K., Hidaka T., Kawakami M., et al. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 1999, 26:1715-1720.
5. Nojima J., Kuratsune H., Suehisa E., Futsukichi Y., Yamanishi H., Machii T., et al. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 2001, 47:1008-1015.
6. Matsubayashi H., Arai T., Izumi S., Sugi T., McIntyre J.A., Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 2001, 76:694-699.
7. Gris J.C., Perneger T.V., Quere I., Mercier E., Fabbro-Peray P., Lavigne-Lissalde G., et al. Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocystein as risk factor for first pregnancy loss: a matched case-control study. Blood 2003, 102:3504-3513.
8. Bizzaro N., Tonutti E., Villalta D., Tampoia M., Tozzoli R. Prevalence and clinical correlation of anti-phospholipid binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch Pathol Lab Med 2005, 129:61-68.
9. 2-glycoprotein I and annexin V in women with early and late idiopathic recurrent spontaneous abortions. Gynecol Obstet 2006, 274:261-265.
10. Sugiura K., Muro Y. Anti-annexin V antibodies and digital ischemia in patients with scleroderma. J Rheumatol 1999, 26:168-172.
11. Tripathy N.K., Sinha N., Nityanand S. Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 2003, 134:360-364.
12. Iłżecka J., Stelmasiak Z. Anti-annexin V antibodies in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosis. Neurol Sci 2003, 24:273-274.
13. Božič B., Irman S., Gašperšič N., Kveder T., Rozman B. Antibodies against annexin A5: detection pitfalls and clinical associations. Autoimmunity 2005, 38:425-430.
14. van Genderen H.O., Kenis H., Hofstra L., Narula J., Reutelingsperger C.P.M. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta 2008, 1783:953-963.
15. 2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005, 6:449-461.
16. Oling F., Bergsma-Schutter W., Brisson A. Trimers, dimers of trimers, trimers of trimers are common building blocks of annexin A5 two-dimensional crystals. J Struct Biol 1998, 133:55-63.
17. van Heerde W.L., Lap P., Schoormans S., de Groot P.G., Reutelingsperger C.P.M., Vroom T.M. Localization of annexin A5 in human tissues. Annexin 2004, 1:56-62.
18. Rand J.H., Wu X.X., Quinn A.S., Taatjes D.J. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome. Lupus 2008, 17:922-930.
19. Ravassa S., Bennaghmouch A., Kenis H., Lindhout T., Hackeng T., Narula J., et al. Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoire. J Biol Chem 2005, 280:6028-6035.
20. Lieby P., Poindron V., Roussi S., Klein C., Knapp A.M., Garaud J.C., et al. Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack. Blood 2004, 104:1711-1715.
21. Gašperšič N., Ambrožič A., Božič B., Majhenc J., Svetina S., Rozman B. Annexin A5 binding to giant phospholipid vesicles is differently affected by anti- β2- glycoprotein I and anti-annexin A5 antibodies. Rheumatology 2007, 46:81-86.
22. Rand J.H., Wu X.X., Guller S., Scher J., Andree H.A., Lockwood C.J. Antiphospholipid immunoglobulin G antibodies reduce annexin V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 1997, 177:918-923.
23. Nakamura N., Ban T., Yamaji K., Yoneda Y., Wada Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V- binding antibody subset. J Clin Invest 1998, 101:1951-1959.
24. Di Simone N., Castellani R., Caliandro D., Caruso A. Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 2001, 65:1766-1770.
25. Wang X., Campos B., Kaetzel M.A., Dedman J.R. Annexin V is critical in the maintenance of murine membrane placental integrity. Am J Obstet Gynecol 1999, 180:1008-1016.
26. Binning G., Quoate C.F., Gerber C.H. Atomic force microscope. Phys Rev Lett 1986, 56:930-933.
27. Božič B., Kveder T., Stegnar M., Marosini-Berus E., Kos-Golja M., Peternel P., et al. Influence of degraded phosphatidylserine on binding of antiphospholipid antibodies. Int Arch Allerg Immunol 1997, 112:19-26.
28. Čučnik S., Križaj I., Rozman B., Kveder T., Božič B. Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I. Clin Chem Lab Med 2004, 42:171-174.
29. Ambrožič A., Kveder T., Žigon P., Božič B. A modified ELISA for the detection of phosphatidylserine dependent anti-prothrombin antibodies with increased sensitivity and specificity. Ann Rheum Dis 2002, 61:218-219.
30. Irman Š, Škarabot M., Muševič I., Rozman B., Božič B. In vitro model of annexin A5 crystallization on natural phospholipid bilayers observed by atomic force microscopy. Autoimmunity 2009, 42:414-423.
31. Richter R.P., Lai Kee Him J., Tessier B., Tessier C., Brisson A. On the kinetics of adsorption and two dimensional self-assembly of annexin A5 on supported lipid bilayers. Biophys J 2005, 89:3372-3385.
32. Richter R.P., Brisson A. Following the formation of supported lipid bilayers on mica: a study combining AFM, QCM-D, and ellipsometry. Biophys J 2005, 88:3422-3433.
33. Reviakine I., Bergsma-Schutter W., Mozorov A.N., Brisson A. Two-dimensional crystallization of annexin A5 on phospholipid bilayers and monolayers: a solid-solid phase transition between crystal forms. Langmuir 2001, 17:1680-1686.
34. Rand J.H., Wu X.X., Quinn A.S., Chen P.P., McCrae K.R., Bovill E.G., et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholpid bilayers: evidence from atomic force microscopy. Am J Pathol 2003, 163:1193-1200.
35. Xu H., Zhao X., Grant C., Lu J.R. Orientation of a monoclonal antibody adsorbed at the solid/solution interface: a combined study using atomic force microscopy and neutron reflectivity. Langmuir 2006, 22:6313-6320.
36. Arnout J., Vermylen J. Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. J Throm Haemost 2002, 1:931-942.
37. Bogdanova N., Horst J., Chlystun M., Croucher P.J.P., Nebel A., Bohring A., et al. A common haplotype of the annexin A5 (ANX A5) gene promoter is associated with recurrent pregnancy loss. Hum Mol Genet 2007, 16:573-578.
38. Chinni E., Luca Tiscia G., Colaizzo D., Vergura P., Margaglione M., Grandone E. Annexin V expression in human placenta is influenced by carriership of the common haplotype M2. Fertil Steril 2009, 91:940-942.
39. De Laat B., Derksen R.H.W.M., Mackie I.J., Roest M., Schoormans S., Woodhams B.J., et al. Annexin A5 polymorphism (-1C→T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann Rheu Dis 2006, 65:1468-1472.
40. Rand J.H. The annexinopathies: a new category of diseases. Biochem Biophys Acta 2000, 1498:169-173.